U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 21:54:11 GMT 2025
Edited
by admin
on Mon Mar 31 21:54:11 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
482M00274D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OCT-2
Common Name English
OCT2
Preferred Name English
ORGANIC CATION TRANSPORTER 2
Common Name English
SLC22A2
Common Name English
SOLUTE CARRIER FAMILY 22 MEMBER 2
Common Name English
Classification Tree Code System Code
UCSF-FDA TRANSPORTAL SLC22A2
Created by admin on Mon Mar 31 21:54:11 GMT 2025 , Edited by admin on Mon Mar 31 21:54:11 GMT 2025
Code System Code Type Description
FDA UNII
482M00274D
Created by admin on Mon Mar 31 21:54:11 GMT 2025 , Edited by admin on Mon Mar 31 21:54:11 GMT 2025
PRIMARY
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_72
Related Record Type Details
Structure of IMATINIB
SUBSTRATE -> TRANSPORTER
Structure of RIBOCICLIB
INHIBITOR -> TRANSPORTER
Structure of FLURAZEPAM
INHIBITOR -> TRANSPORTER
Structure of SEPANTRONIUM BROMIDE
INHIBITOR -> TRANSPORTER
Structure of Desloratadine
INHIBITOR -> TRANSPORTER
Structure of PANOBINOSTAT
INHIBITOR -> TRANSPORTER
Structure of PONATINIB
NON-SUBSTRATE -> TRANSPORTER
Structure of DASATINIB
INHIBITOR -> TRANSPORTER
Structure of SUNITINIB
INHIBITOR -> TRANSPORTER
Structure of Olaparib
INHIBITOR -> TRANSPORTER
Structure of DIPHENHYDRAMINE
INHIBITOR -> TRANSPORTER
Structure of MEXILETINE
INHIBITOR -> TRANSPORTER
Structure of TETRAPENTYLAMMONIUM
INHIBITOR -> TRANSPORTER
Structure of ATROPINE
INHIBITOR -> TRANSPORTER
Structure of CARVEDILOL
INHIBITOR -> TRANSPORTER
Structure of IMIPRAMINE
INHIBITOR -> TRANSPORTER
Structure of TETRAETHYLAMMONIUM
INHIBITOR -> TRANSPORTER
Structure of GEFITINIB
SUBSTRATE -> TRANSPORTER
Structure of TAMOXIFEN
INHIBITOR -> TRANSPORTER
Structure of BRANEBRUTINIB
INHIBITOR -> TRANSPORTER
Structure of KETAMINE
INHIBITOR -> TRANSPORTER
Structure of FENFLURAMINE
INHIBITOR -> TRANSPORTER
Structure of AMANTADINE
SUBSTRATE -> TRANSPORTER
Structure of CLONIDINE
INHIBITOR -> TRANSPORTER
Structure of VANDETANIB
INHIBITOR -> TRANSPORTER
Structure of ERLOTINIB
SUBSTRATE -> TRANSPORTER
Structure of METHAMPHETAMINE
INHIBITOR -> TRANSPORTER
IC50
Structure of CIMETIDINE
SUBSTRATE -> TRANSPORTER
Structure of TAFENOQUINE
INHIBITOR -> TRANSPORTER
corrected for non-specific binding
IC50
Structure of CREATININE
SUBSTRATE -> TRANSPORTER
Structure of Solriamfetol
INHIBITOR -> TRANSPORTER
WEAK
IC50
Structure of MEMANTINE
SUBSTRATE -> TRANSPORTER
Structure of GILTERITINIB
INHIBITOR -> TRANSPORTER
WEAK
IC50
Structure of Nilotinib
SUBSTRATE -> TRANSPORTER
Structure of Bictegravir
INHIBITOR -> TRANSPORTER
Co?administration of BIKTARVY with dofetilide may increase dofetilide plasma concentrations which can lead to serious and/or life threatening events.
IC50
Structure of IPTACOPAN
NON-SUBSTRATE -> TRANSPORTER
Structure of TRIMETHOPRIM
INHIBITOR -> TRANSPORTER
Structure of ERLOTINIB
INHIBITOR -> TRANSPORTER
Structure of MIDOMAFETAMINE
INHIBITOR -> TRANSPORTER
Structure of Amitriptyline
INHIBITOR -> TRANSPORTER
Structure of QUININE
INHIBITOR -> TRANSPORTER
Structure of Ipratropium bromide
INHIBITOR -> TRANSPORTER
Structure of COCAINE
INHIBITOR -> TRANSPORTER
Structure of COBICISTAT
INHIBITOR -> TRANSPORTER
Structure of CHLOROQUINE
INHIBITOR -> TRANSPORTER
Structure of IMEGLIMIN
INHIBITOR -> TRANSPORTER
Structure of DESIPRAMINE
INHIBITOR -> TRANSPORTER
Structure of PYRIDINE
INHIBITOR -> TRANSPORTER
Structure of CIMETIDINE
INHIBITOR -> TRANSPORTER
Structure of GEFITINIB
INHIBITOR -> TRANSPORTER
Structure of 1-Hexylpyridinium chloride
INHIBITOR -> TRANSPORTER
Structure of CORTICOSTERONE
INHIBITOR -> TRANSPORTER
Structure of ABAMETAPIR
INHIBITOR -> TRANSPORTER
but the ratio of the unbound Cmax to the IC50 is less than 0.1
IC50
Structure of RANITIDINE
INHIBITOR -> TRANSPORTER
Structure of IMEGLIMIN
SUBSTRATE -> TRANSPORTER
Structure of AMANTADINE
INHIBITOR -> TRANSPORTER
Structure of 1-BUTYL-1-METHYLPYRROLIDINIUM CHLORIDE
INHIBITOR -> TRANSPORTER
Structure of MEFLOQUINE
INHIBITOR -> TRANSPORTER
Structure of DIZOCILPINE
INHIBITOR -> TRANSPORTER
Structure of PHENCYCLIDINE
INHIBITOR -> TRANSPORTER
Structure of FLECAINIDE
INHIBITOR -> TRANSPORTER
Structure of GREPAFLOXACIN
INHIBITOR -> TRANSPORTER
Structure of PRAZOSIN
INHIBITOR -> TRANSPORTER
Structure of DASATINIB
SUBSTRATE -> TRANSPORTER
Structure of PHENFORMIN
INHIBITOR -> TRANSPORTER
Structure of Binimetinib
INHIBITOR -> TRANSPORTER
MINOR
IC50
Structure of 1-ETHYLPYRIDINIUM CHLORIDE
INHIBITOR -> TRANSPORTER
Structure of IMATINIB
INHIBITOR -> TRANSPORTER
Structure of PHENOXYBENZAMINE
INHIBITOR -> TRANSPORTER
Structure of FURAMIDINE
INHIBITOR -> TRANSPORTER
Structure of PENTAMIDINE
INHIBITOR -> TRANSPORTER
Structure of BMS-986299
INHIBITOR -> TRANSPORTER
Structure of ABAMETAPIR CARBOXYL
INHIBITOR -> TRANSPORTER
Structure of DISOPYRAMIDE
INHIBITOR -> TRANSPORTER
Structure of PSEUDOISOCYANINE IODIDE
INHIBITOR -> TRANSPORTER
Structure of SIBUTRAMINE
INHIBITOR -> TRANSPORTER
Structure of VERAPAMIL
INHIBITOR -> TRANSPORTER
Structure of PROPAFENONE
INHIBITOR -> TRANSPORTER
Structure of PROPRANOLOL
INHIBITOR -> TRANSPORTER
Structure of MEPIPERPHENIDOL
INHIBITOR -> TRANSPORTER
Structure of Metformin
SUBSTRATE -> TRANSPORTER
Structure of CETIRIZINE
INHIBITOR -> TRANSPORTER
Structure of LEVOMETHADONE
INHIBITOR -> TRANSPORTER
Structure of FEDRATINIB
INHIBITOR -> TRANSPORTER
IC50
Structure of PILSICAINIDE
INHIBITOR -> TRANSPORTER
Structure of DEXTROAMPHETAMINE
INHIBITOR -> TRANSPORTER
Structure of OXALIPLATIN
SUBSTRATE -> TRANSPORTER
Structure of QUINIDINE
INHIBITOR -> TRANSPORTER
Structure of ENCORAFENIB
INHIBITOR -> TRANSPORTER
IC50
Structure of BUTYLSCOPOLAMINE
INHIBITOR -> TRANSPORTER
Structure of Teriflunomide
INHIBITOR -> TRANSPORTER
Terifluniomide is an inhibitor of BCRP, OAT3, OATP1B1, OCT2 in vitro
Structure of BUTYLMETHYLIMIDAZOLIUM CHLORIDE
INHIBITOR -> TRANSPORTER
Structure of N-BUTYLPYRIDINIUM CHLORIDE
INHIBITOR -> TRANSPORTER
Structure of FAMOTIDINE
INHIBITOR -> TRANSPORTER
DOXEPIN
INHIBITOR -> TRANSPORTER
Structure of METHAMPHETAMINE
SUBSTRATE -> TRANSPORTER
Structure of MEMANTINE
INHIBITOR -> TRANSPORTER
Structure of CHLORPROMAZINE
INHIBITOR -> TRANSPORTER
Structure of AMPHETAMINE
SUBSTRATE -> TRANSPORTER
Structure of TESTOSTERONE
INHIBITOR -> TRANSPORTER
Structure of Tirbanibulin
INHIBITOR -> TRANSPORTER
The results suggest that KLISYRI has no clinically meaningful effect on the PK of drugs mediated by OCT2
IC50
Structure of DX-619
INHIBITOR -> TRANSPORTER
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966